Nicolet Bankshares »

Summit Therapeutics shares owned by Nicolet Bankshares

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Nicolet Bankshares from 13F filings

Historical chart of Nicolet Bankshares investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Nicolet Bankshares consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Nicolet Bankshares

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1M 73k 14.57

More positions owned by Nicolet Bankshares

State Street Spdr Other (SPYM)
Spdr Ser Tr Other (SPYV)
Apple Common Stock (AAPL)
American Centy Etf Tr Other (AVEM)
Spdr Ser Tr Other (SPYG)
Vanguard Tax-managed Fds Other (VEA)
Vanguard Index Fds Other (VOO)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Morn Mid Cap Etf Other (VO)
Fidelity Merrimack Str Tr Other (FBND)
Nvidia Corporation Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Vanguard Mun Bd Fds Other (VTEB)
Schwab Strategic Tr Other (SCHV)
Ishares Tr Other (MUB)

View all positions for Nicolet Bankshares

Top funds holding Summit Therapeutics

Baker Bros. Advisors
FMR
BlackRock
T. Rowe Price Associates
State Street Corporation
Vanguard Capital Management
UBS Group
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Geode Capital Management
Citadel Advisors
Susquehanna International
Millennium Management
Adage Capital Partners GP

View all funds holding Summit Therapeutics